白血病中的P2X7受体:病理机制和治疗潜力
Yanwen Xue1,2, Xiaoxiang Peng1,2, Meng Yan1,2
1School of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, China.
Purinergic signalling
|August 22, 2025
概括
P2X7受体与白血病的发展和进展有关. 针对该受体,特别是用抑制剂, 显示为白血病患者的新疗法.
科学领域:
- 免疫学
- 癌症学
- 药理学
背景情况:
- P2X7受体是一个三元离子通道,参与炎症性疾病和癌症.
- 白血病是一种造血干细胞疾病,通常用化疗治疗,但有副作用.
- 针对性治疗正在成为白血病的新疗法.
研究的目的:
- 研究P2X7受体在白血病中的作用.
- 探索P2X7受体作为白血病治疗点的潜力.
主要方法:
- 对癌症和白血病中的P2X7受体现有研究的综述.
- 对P2X7受体在白血病细胞迁移和入侵中的参与进行分析.
- 检查P2X7受体基因多态性对白血病的影响.
主要成果:
- P2X7受体与白血病的发生和进展有显著的关系.
- P2X7受体影响白血病细胞的迁移和入侵.
- 在P2X7受体基因的多态性影响白血病的发展和临床过程.
结论:
- P2X7受体是白血病的潜在治疗点.
- P2X7受体抑制剂可能增强现有的白血病治疗方法.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K


